The cumulative risk of developing ovarian cancer has been reported as 39–44% for BRCA1 mutations and 11–17% for BRCA2 mutations, compared to a cumulative risk of ovarian cancer in the general population of 1–2% [2]. The gene discussed is BRCA2; the disease is ovarian carcinoma.